CRNX vs ROIV
Crinetics Pharmaceuticals, Inc. · Roivant Sciences Ltd.
Relative return (rebased to 100)
Key stats
| Metric | CRNX | ROIV |
|---|---|---|
| Price | $84.95 | $35.53 |
| Market Cap | $9.01B | $25.66B |
| P/E | — | — |
| P/B | 7.56 | 6.07 |
| P/S | 1170.77 | 3107.04 |
| ROE | -39.0% | -7.1% |
| Net Margin | -6046.2% | -3629.2% |
| Gross Margin | — | — |
| Revenue Growth | 640.7% | -71.6% |
| Dividend Yield | — | — |
| EPS | -$4.39 | -$0.42 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.